Our Services
Medical Information
Helpful Resources
Published on: 9/12/2026
Dark thoughts or new suicidal ideation after starting escitalopram, changing your dose, or stopping it should always be treated as urgent, and they are most common in the first few weeks and in people under 25. Stopping the medication abruptly on your own is generally not advised, because sudden discontinuation can trigger withdrawal effects such as dizziness, irritability, insomnia, and worsening mood, which may make the thoughts feel more intense; any change is safest when guided by your prescriber, who may taper the dose, adjust it, or switch medications. Timing, dose, other medications, alcohol use, and your personal history all matter here, so see below for the important details to consider before making any decision, and get emergency help right away if you feel you might act on these thoughts.
If you are unsure whether what you are feeling is a medication side effect, a return of depression, or something else entirely, a few minutes of structured questions can help you sort it out. Take a free, instant, online symptom check to better understand what may be driving your symptoms and what to discuss with your prescriber next.
Last reviewed for medical accuracy: 09/12/2026
Escitaloprám (often known by its brand name, Lexapro) is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for depression and anxiety. While it helps many people feel better, a small number—especially young adults—may experience new or worsening dark thoughts, including suicidal ideation. If you’re taking escitaloprám and notice distressing changes in your mood or thoughts, here’s what you need to know.
• SSRI Mechanism: Escitaloprám increases serotonin levels in the brain, improving mood and reducing anxiety over several weeks.
• Risk Window: New or intensified suicidal thoughts can occur most often during the first few weeks of treatment or after a dose change.
• Who’s at Risk: Teenagers, young adults (18–24), and people with a prior history of suicidal ideation may be more vulnerable.
These changes do not mean escitaloprám is “making you” think dark thoughts, but rather that your brain chemistry is shifting. Your body may need time to adjust.
Stopping escitaloprám suddenly can trigger:
Safe discontinuation or dose adjustments should always be guided by a healthcare professional.
Contact Your Prescriber Immediately
• Call your psychiatrist, primary care doctor or mental health provider.
• Describe what you’re experiencing: timing, frequency, and intensity of thoughts.
• Don’t wait for your next scheduled visit—reach out as soon as possible.
Consider a Free, Online Symptom Check
If you’re unsure whether your symptoms warrant a call, try a
free, online symptom check, using the doctor approved Ubie Symptom Checker.
It can help you decide if you need urgent medical attention or a prescription review.
Enlist a Trusted Friend or Family Member
• Let someone know you’re having dark thoughts.
• Ask them to check in on you regularly.
• Consider staying with them until you’ve spoken to a healthcare professional.
Seek Emergency Help If Thoughts Become Urgent
• If you feel you might act on suicidal thoughts, call emergency services (e.g., 911 in the U.S.) or go to your nearest emergency department.
• In the U.S., you can also dial 988 to connect with the Suicide and Crisis Lifeline.
• If you’re outside the U.S., look up your local crisis hotline number now so you have it ready.
When you speak to your healthcare provider, they may suggest:
Even with professional guidance, you can take steps to support your mental health:
• Maintain a daily routine: regular sleep, balanced meals, and exercise.
• Keep a mood journal: note changes in thoughts, sleep, appetite, and energy.
• Practice stress‐reduction techniques: deep breathing, mindfulness, or yoga.
• Stay connected: reach out to friends, family, or support groups.
• Limit alcohol and recreational drugs: they can worsen dark thoughts and interact with your medication.
Seek immediate help if you experience any of the following:
These are signs of a mental health emergency. Talk to a doctor or go to an emergency department right away.
Most people who experience early side effects on escitaloprám do not go on to have lasting problems. With careful monitoring and open communication, you and your doctor can:
Remember, asking for help is a sign of strength—never a weakness.
If you’re feeling unsafe with your thoughts or if anything feels life‐threatening or seriously out of control, please speak to a doctor or mental health professional right away. You don’t have to face this alone—help is available.
(References)
* Yuksel FV, Tuzer V, Goka E. Escitalopram intoxication. Eur Psychiatry. 2005 Jan;20(1):82. doi: 10.1016/j.eurpsy.2004.06.034. PMID: 15642453.
* Cooper WO, Callahan ST, Shintani A, Fuchs DC, Shelton RC, Dudley JA, Graves AJ, Ray WA. Antidepressants and suicide attempts in children. Pediatrics. 2014 Feb;133(2):204-10. doi: 10.1542/peds.2013-0923. Epub 2014 Jan 6. PMID: 24394688; PMCID: PMC3904271.
* Bazigh I, Dharmapuri S, Cosme RM. Transient Subclinical Hypothyroidism and Acute Suicidal Ideation Following Treatment with Escitalopram. Cureus. 2019 Jul 15;11(7):e5144. doi: 10.7759/cureus.5144. Epub 2019 Jul 15. PMID: 31523572; PMCID: PMC6741397.
* Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, Cox GR, Merry SN, Meader N. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev. 2021 May 24;5(5):CD013674. doi: 10.1002/14651858.CD013674.pub2. Epub 2021 May 24. PMID: 34029378; PMCID: PMC8143444.
* Edinoff AN, Akuly HA, Hanna TA, Ochoa CO, Patti SJ, Ghaffar YA, Kaye AD, Viswanath O, Urits I, Boyer AG, Cornett EM, Kaye AM. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review. Neurol Int. 2021 Aug 5;13(3):387-401. doi: 10.3390/neurolint13030038. Epub 2021 Aug 5. PMID: 34449705; PMCID: PMC8395812.
* Lagerberg T, Fazel S, Sjölander A, Hellner C, Lichtenstein P, Chang Z. Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study. Neuropsychopharmacology. 2022 Mar;47(4):817-823. doi: 10.1038/s41386-021-01179-z. Epub 2021 Sep 24. PMID: 34561608; PMCID: PMC8882171.
* Yatham LN, Arumugham SS, Kesavan M, Ramachandran K, Murthy NS, Saraf G, Ouyang Y, Bond DJ, Schaffer A, Ravindran A, Ravindran N, Frey BN, Daigneault A, Beaulieu S, Lam RW, Kondapuram N, Reddy MS, Bhandary RP, Ashok MV, Ha K, Ahn YM, Milev R, Wong H, Reddy YCJ, BEAM-BD Trial Group. Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression. N Engl J Med. 2023 Aug 3;389(5):430-440. doi: 10.1056/NEJMoa2300184. PMID: 37530824.
* Olgiati P, Pecorino B, Serretti A. Suicide ideation and male-female differences in major depressive disorder. Int J Psychiatry Clin Pract. 2024 Mar;28(1):53-62. doi: 10.1080/13651501.2024.2335950. Epub 2024 Apr 8. PMID: 38587055.
* Rowe J, Nogovitsyn N, Mazurka R, Squires SD, Hassel S, Poppenk J, Dunlop K, Zamyadi M, Milev RV, Foster JA, Arnott SR, Lam RW, Uher R, Rotzinger S, Kennedy SH, Frey BN, Harkness KL. Latent Profile Analysis of Childhood Maltreatment and Neural Markers in Depression. JAMA Netw Open. 2025 Aug 1;8(8):e2525147. doi: 10.1001/jamanetworkopen.2025.25147. Epub 2025 Aug 1. PMID: 40758349; PMCID: PMC12322798.
* Türkmen C, Sacu S, Furukawa Y, de Cates AN, Schoevers RA, Kamphuis J, Chevance A, Weisz JR, Emslie GJ, Strawn JR, Hetrick SE, Efthimiou O, Salanti G, van Dalfsen JH, Furukawa TA, Cipriani A. Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysis. BMJ Open. 2025 Oct 7;15(10):e102696. doi: 10.1136/bmjopen-2025-102696. Epub 2025 Oct 7. PMID: 41062142; PMCID: PMC12506116.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.